Planet Labs PBC(PL) - 2025 Q4 - Annual Results

Revenue Performance - Fourth quarter revenue reached a record $61.6 million, representing a 5$244.4 million, marking an 11% year-over-year growth[3] - The Company reported revenue of $61,554,000 for the three months ended January 31, 2025, representing an increase of 2.9$58,852,000 for the same period in 2024[41] Gross Margin and Profitability - The company achieved a fourth quarter gross margin of 62%, up from 55% in the same quarter of the previous fiscal year[3] - Gross profit for the three months ended January 31, 2025, was $38,215,000, up from$32,481,000 in the prior year, indicating a gross margin improvement[41] - The GAAP gross profit for the year ended January 31, 2025, was $139,725 thousand, up from$112,950 thousand in 2024, reflecting a growth of 23.7%[48] - Non-GAAP gross profit for the year ended January 31, 2025, was $147,517 thousand, compared to$119,877 thousand in 2024, representing a 23.2% increase[48] Operating Expenses and Losses - The Company incurred a net loss of $35,154,000 for the three months ended January 31, 2025, compared to a net loss of$30,086,000 for the same period in 2024, reflecting increased operating expenses[41] - Total operating expenses decreased to $57,581,000 for the three months ended January 31, 2025, from$66,399,000 in the same period of 2024, primarily due to reduced research and development costs[41] - The net loss for the three months ended January 31, 2025, was $35,154 thousand, compared to a net loss of$30,086 thousand for the same period in 2024, representing an increase of 10.5%[43] - For the year ended January 31, 2025, the net loss was $123,196 thousand, a decrease of 12.3$140,509 thousand in 2024[45] - The company reported a comprehensive loss of $37,598 thousand for the three months ended January 31, 2025, compared to a comprehensive loss of$28,250 thousand in 2024, indicating a 33.1% increase[43] Cash and Investments - Planet's cash, cash equivalents, and short-term investments stood at approximately $222.1 million at the end of the quarter[2][7] - The Company’s cash and cash equivalents increased to$118,048,000 as of January 31, 2025, compared to $83,866,000 as of January 31, 2024[39] - Cash and cash equivalents at the end of the period increased to$129,994 thousand from $102,198 thousand at the beginning of the period, marking a net increase of$27,796 thousand[45] Backlog and Future Expectations - The backlog increased to $498.5 million, reflecting a 115$498,458,000 as of January 31, 2025, up from $232,140,000 in the previous quarter, reflecting a 114.5$260 million and $280 million[12] - The company anticipates a Non-GAAP gross margin of approximately 55$407,538,000, with an expectation to recognize approximately 38% over the next 12 months[52] - The company expects to recognize approximately 70% of remaining performance obligations over the next 24 months[52] Research and Development - The company incurred $22,951 thousand in GAAP research and development expenses for the three months ended January 31, 2025, down from$28,410 thousand in 2024, a decrease of 19.2%[49] Employee-Related Costs - The company recognized $10.6 million in severance and other employee-related costs as part of the 2024 headcount reduction[47] - Stock-based compensation for the three months ended January 31, 2025, was$12,018,000, slightly down from $12,521,000 in the same period of 2024[50] - The company incurred restructuring costs of$50,000 for the three months ended January 31, 2025, compared to $35,000 in the same period of 2024[50] - The amortization of acquired intangible assets was$867,000 for the three months ended January 31, 2025, down from $1,149,000 in the same period of 2024[50] Shareholder Metrics - The weighted-average shares used in computing GAAP net loss per share, basic and diluted, was 296,441,988 for the three months ended January 31, 2025[50] - GAAP net loss per share, diluted, was$0.12 for the three months ended January 31, 2025, compared to $0.11 for the same period in 2024[50]